PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
56 hedge funds and large institutions have $288M invested in Poseida Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
Holders
56
Holding in Top 10
1
Calls
$2K
Puts
$4K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$6.51M | |
| 3 | +$1.1M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$962K |
| 5 |
State Street
Boston,
Massachusetts
|
+$605K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$2.36M | |
| 3 | -$1.57M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$1.32M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$853K |